LEIGH JOHNSON: Open Payments
NPI 1437882776 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 49 payments from 8 companies in 2025. Trend: 2023 $1,338 · 2024 $1,396 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $331 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $190 |
| Novo Nordisk Inc | 3 | $145 |
| Alnylam Pharmaceuticals Inc. | 6 | $105 |
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| BridgeBio Pharma, Inc. | 1 | $29 |
| ABIOMED | 1 | $14 |
Products named: LEQVIO, JARDIANCE, Ozempic, AMVUTTRA, WAINUA, VERQUVO, Attruby, Wegovy.
Industry payments across AR — which companies pay providers there.
